NCT05149222View on ClinicalTrials.gov

"REACT-FM-EXT: Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study"

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

April 14, 2024

Study Completion Date

April 14, 2024

Conditions
Fibromyalgia
Interventions
DEVICE

Digital ACT

This is a virtual, single-arm, non-significant risk study. Study participants will receive 9 months of Digital Acceptance and Commitment Therapy (ACT) in addition to their standard care for fibromyalgia.

Trial Locations (1)

94111

Swing Therapeutics, San Francisco

All Listed Sponsors
lead

Swing Therapeutics, Inc.

OTHER

NCT05149222 - "REACT-FM-EXT: Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study" | Biotech Hunter | Biotech Hunter